Todos Med Ltd (TOMDF)

[arpemd]

mebbe, but

https://seekingalpha.com/pr/18647492-todos-medical-and-nlc-pharma-announce-primary-and-secondary-endpoints-met-in-nlc-vminus-01

JP, note those words: "interim analysis", meaning the trial was closed early due to endpoints being reached extremely quickly.

that's the good news. The bad news is, that the trial REALLY needs more peeps a la sabizabulin to catch the eye of reg agencies and other peeps.